A Virtual Reality Study: Skin Clearance, Quality of Life and Other Patient-Facing Psoriasis Goals: Implications of Biologic Treatment

REGISTER NOW!
Already Registered?
SIGN IN

WEBCAST DATE

Friday, November 2, 2018

10:00 AM Eastern    9:00 AM Central    8:00 AM Mountain    7:00 AM Pacific

PROGRAM FEATURES

• Virtual reality headsets provided to enhance learning experience
• Case-based learning environment

FACULTY

Junko Takeshita, MD, PhD
Clinical Instructor Dept. of Dermatology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

AGENDA

Part 1 – Introduction
• Epidemiology
• Pathophysiology
• Clinical course

Part 2 – Evolving Landscape of Psoriasis Management
• Development of targeted therapies
• PASI75 vs PASI90 and PASI100
• Psoriasis and psoriatic arthritis

Part 3 – Integrating Biologics in Long-Term Management of Psoriasis
• Biologic therapies
• Agents targeting TNF-α, IL-23, IL-17 and other pathways
• Efficacy, safety, tolerability and other considerations

Part 4 – Optimizing Psoriasis Management in the Context of Associated Comorbidities
• Comorbidities of psoriasis
• Cardiovascular risk factors and CVD in psoriasis
• CVD risk assessment: recommendations
• Impact of psoriasis treatment on CVD

Part 5 – Patient-Facing Goals in Psoriasis
• Psoriasis: the patient burden
• Quality of life
• Work productivity
• The pursuit of complete skin clearance
• Improved physical function, sustained reduction of pain and structural damage

Conclusions

Questions & Answers

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the rationale for evolving PASI goals, from PASI 75 to PASI 90 and 100
• Review the relationship between psoriasis and cardiometabolic disease to more comprehensively manage the psoriasis patient
• Assess response kinetics, symptoms, quality of life, and overall patient-focused therapeutic goals based on approved and investigational targeted biologics

TARGET AUDIENCE

This activity is intended for dermatologists, physician assistants, nurses and nurse practitioners who are involved in the management of patients with psoriasis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the long-term treatment and management of patients with psoriasis.

Credits:
1.0 ANCC Contact Hours

CNE Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.